-transparent.png){kind=logo}
BACKGROUND Endogenous opioids have a tonic inhibitory effect on sympathetic tone and have been implicated in the pathophysiology of vasodepressor syncope. Plasma beta endorphin concentrations increase after vasodepressor syncope induced by exercise or by fasting. OBJECTIVE To take frequent samples for plasma beta endorphin estimation during tilt testing, and to determine whether plasma beta endorphin increased before the start of syncope. METHODS 24 patients undergoing tilt testing for investigation of unexplained syncope. METHODS Tertiary referral centre. METHODS Blood samples were obtained during 70 degrees head up tilt testing. Plasma beta endorphin concentrations were estimated by radioimmunoassay (mean(SD) pmol/l). RESULTS Patients with a positive test showed a rise in beta endorphin concentrations before syncope baseline 4.4(1.5) v start of syncope 8.5(3.1), p < 0.002). In contrast, patients with a negative test showed no change in beta endorphin concentrations (baseline 3.4(1.0) v end of test 4.5(2.3), NS). After syncope all patients showed a large secondary increase in beta endorphins (32.3(18.6)). CONCLUSIONS An increase in plasma beta endorphins precedes vasodepressor syncope. This finding supports a pathophysiological role for endogenous opioids.
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
May 1995,
British heart journal,
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
April 1990,
The American journal of cardiology,
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
January 1989,
General pharmacology,
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
January 1990,
Journal (Canadian Dental Association),
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
August 2000,
Current treatment options in cardiovascular medicine,
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
June 1993,
Herz,
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
May 1998,
The Journal of the Arkansas Medical Society,
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
May 1959,
American heart journal,
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
November 1994,
American heart journal,
D R Wallbridge, and
H E MacIntyre, and
C E Gray, and
M A Denvir, and
K G Oldroyd, and
A P Rae, and
S M Cobbe
April 1991,
The New England journal of medicine,
